The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H2-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy | Zendy

Bogdan Superceanu | Zendy; Sander Veldhuyzen van Zanten | Zendy; Chris Skedgel | Zendy; Michael Shepherd | Zendy; Ingrid Sketris | Zendy

Open Access

The Rate of Prescribing Gastrointestinal Prophylaxis with Either a Proton Pump Inhibitor Or an H₂-Receptor Antagonist in Nova Scotia Seniors Starting Nonsteroidal Anti-Inflammatory Drug Therapy

Author(s) -

Bogdan Superceanu,

Sander Veldhuyzen van Zanten,

Chris Skedgel,

Michael Shepherd,

Ingrid Sketris

Publication year - 2010

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2010/397610

Subject(s) - medicine , nova scotia , medical prescription , proton pump inhibitor , cohort , nonsteroidal , drug , gastroenterology , pharmacology , archaeology , history

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used agents that can cause serious gastrointestinal (GI) side effects. For patients at increased risk of NSAID-related GI complications, prophylaxis with either a nonselective NSAID plus gastroprotective agent (GPA) or, alternatively, therapy with a cyclooxygenase-2 selective inhibitor with or without a GPA such as a proton pump inhibitor (PPI), is recommended.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research